瑞银-恒瑞医药(600276):2026年A股交流会:创新药销量下半年环比复苏,合作与研发进展顺利-Jiangsu Hengrui Pharmaceuticals-A 2026 A-share Conference:innovative sales recovering sequentially in H2;partnership-20260902【12页】

发表回复

后才能评论